Literature DB >> 25234843

Neighborhood socioeconomic deprivation, tumor subtypes, and causes of death after non-metastatic invasive breast cancer diagnosis: a multilevel competing-risk analysis.

Min Lian1, Maria Pérez, Ying Liu, Mario Schootman, Ann Frisse, Ellen Foldes, Donna B Jeffe.   

Abstract

The purpose of this study is to examine the associations of neighborhood socioeconomic deprivation and triple-negative breast cancer (TNBC) subtype with causes of death [breast cancer (BC)-specific and non-BC-specific] among non-metastatic invasive BC patients. We identified 3,312 patients younger than 75 years (mean age 53.5 years; 621 [18.8 %] TNBC) with first primary BC treated at an academic medical center from 1999 to 2010. We constructed a census-tract-level socioeconomic deprivation index using the 2000 U.S. Census data and performed a multilevel competing-risk analysis to estimate the hazard ratios (HR) and 95 % confidence intervals (CI) of BC-specific and non-BC-specific mortality associated with neighborhood socioeconomic deprivation and TNBC subtype. The adjusted models controlled for patient sociodemographics, health behaviors, tumor characteristics, comorbidity, and cancer treatment. With a median 62-month follow-up, 349 (10.5 %) patients died; 233 died from BC. In the multivariate models, neighborhood socioeconomic deprivation was independently associated with non-BC-specific mortality (the most- vs. the least-deprived quartile: HR = 2.98, 95 % CI = 1.33-6.66); in contrast, its association with BC-specific mortality was explained by the aforementioned patient-level covariates, particularly sociodemographic factors (HR = 1.15, 95 % CI = 0.71-1.87). TNBC subtype was independently associated with non-BC-specific mortality (HR = 2.15; 95 % CI = 1.20-3.84), while the association between TNBC and BC-specific mortality approached significance (HR = 1.42; 95 % CI = 0.99-2.03, P = 0.057). Non-metastatic invasive BC patients who lived in more socioeconomically deprived neighborhoods were more likely to die as a result of causes other than BC compared with those living in the least socioeconomically deprived neighborhoods. TNBC was associated with non-BC-specific mortality but not BC-specific mortality.

Entities:  

Mesh:

Year:  2014        PMID: 25234843      PMCID: PMC4181526          DOI: 10.1007/s10549-014-3135-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  35 in total

1.  Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.

Authors:  C S Thomson; D J Hole; C J Twelves; D H Brewster; R J Black
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  Geographic and racial disparities in breast cancer-related outcomes in Georgia.

Authors:  Talar W Markossian; Robin B Hines; Rana Bayakly
Journal:  Health Serv Res       Date:  2013-08-01       Impact factor: 3.402

3.  Disentangling contextual effects on cause-specific mortality in a longitudinal 23-year follow-up study: impact of population density or socioeconomic environment?

Authors:  Basile Chaix; Maria Rosvall; John Lynch; Juan Merlo
Journal:  Int J Epidemiol       Date:  2006-02-01       Impact factor: 7.196

4.  Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.

Authors:  V L Ernster; J Barclay; K Kerlikowske; H Wilkie; R Ballard-Barbash
Journal:  Arch Intern Med       Date:  2000-04-10

Review 5.  The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

Review 6.  Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit?

Authors:  Bevan H Ly; Nam P Nguyen; Vincent Vinh-Hung; Elisabetta Rapiti; Georges Vlastos
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

7.  The effect of comorbidity on 3-year survival of women with primary breast cancer.

Authors:  W A Satariano; D R Ragland
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

8.  Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.

Authors:  Jennifer L Patnaik; Tim Byers; Carolyn DiGuiseppi; Dana Dabelea; Thomas D Denberg
Journal:  Breast Cancer Res       Date:  2011-06-20       Impact factor: 6.466

9.  Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer.

Authors:  A Downing; K Prakash; M S Gilthorpe; J S Mikeljevic; D Forman
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

10.  Comparing GIS-based measures in access to mammography and their validity in predicting neighborhood risk of late-stage breast cancer.

Authors:  Min Lian; James Struthers; Mario Schootman
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more
  14 in total

1.  Influence of neighborhood-level factors on social support in early-stage breast cancer patients and controls.

Authors:  Tess Thompson; Thomas L Rodebaugh; Maria Pérez; James Struthers; Julianne A Sefko; Min Lian; Mario Schootman; Donna B Jeffe
Journal:  Soc Sci Med       Date:  2016-03-17       Impact factor: 4.634

2.  Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype.

Authors:  Ines Mesa-Eguiagaray; Sarah H Wild; Sheila M Bird; Linda J Williams; David H Brewster; Peter S Hall; Jonine D Figueroa
Journal:  Breast Cancer Res Treat       Date:  2022-06-01       Impact factor: 4.624

3.  Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer.

Authors:  Yunan Han; Zhi-Feng Miao; Min Lian; Lindsay L Peterson; Graham A Colditz; Ying Liu
Journal:  Breast Cancer Res Treat       Date:  2020-09-14       Impact factor: 4.872

4.  Influence of built environment on quality of life changes in African-American patients with non-metastatic breast cancer.

Authors:  M Schootman; M Perez; J C Schootman; Q Fu; A McVay; J Margenthaler; G A Colditz; M W Kreuter; D B Jeffe
Journal:  Health Place       Date:  2020-05-11       Impact factor: 4.078

5.  Impacts of Neighborhood Characteristics on Treatment and Outcomes in Women with Ductal Carcinoma In Situ of the Breast.

Authors:  Shiyang Zhang; Ying Liu; Shumei Yun; Min Lian; Goldie Komaie; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-14       Impact factor: 4.254

6.  Neighborhood archetypes and breast cancer survival in California.

Authors:  Salma Shariff-Marco; Mindy C DeRouen; Juan Yang; Jennifer Jain; David O Nelson; Margaret M Weden; Scarlett L Gomez
Journal:  Ann Epidemiol       Date:  2021-02-10       Impact factor: 3.797

7.  Geographic Variation in Maternal Smoking during Pregnancy in the Missouri Adolescent Female Twin Study (MOAFTS).

Authors:  Min Lian; Pamela A Madden; Michael T Lynskey; Graham A Colditz; Christina N Lessov-Schlaggar; Mario Schootman; Andrew C Heath
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

8.  Measuring Subcounty Differences in Population Health Using Hospital and Census-Derived Data Sets: The Missouri ZIP Health Rankings Project.

Authors:  Elna Nagasako; Brian Waterman; Mathew Reidhead; Min Lian; Sarah Gehlert
Journal:  J Public Health Manag Pract       Date:  2018 Jul/Aug

9.  Neighborhood Characteristics and Colorectal Cancer Survivors' Quality of Care.

Authors:  Ulrike Boehmer; Jennifer Potter; Melissa A Clark; Al Ozonoff; Rachel M Ceballos; Michael Winter; Kevan L Hartshorn
Journal:  Health Equity       Date:  2019-12-13

10.  Relationship between insurance status and outcomes for patients with breast cancer in Missouri.

Authors:  Jennifer L Berrian; Ying Liu; Min Lian; Chester L Schmaltz; Graham A Colditz
Journal:  Cancer       Date:  2020-11-17       Impact factor: 6.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.